CN117265002A - Application of disease-resistant gene NtTBWRG1 in prevention and treatment of tobacco bacterial wilt - Google Patents
Application of disease-resistant gene NtTBWRG1 in prevention and treatment of tobacco bacterial wilt Download PDFInfo
- Publication number
- CN117265002A CN117265002A CN202311200356.5A CN202311200356A CN117265002A CN 117265002 A CN117265002 A CN 117265002A CN 202311200356 A CN202311200356 A CN 202311200356A CN 117265002 A CN117265002 A CN 117265002A
- Authority
- CN
- China
- Prior art keywords
- nttbwrg1
- bacterial wilt
- disease
- gene
- tobacco
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000001580 bacterial effect Effects 0.000 title claims abstract description 53
- 235000002637 Nicotiana tabacum Nutrition 0.000 title claims abstract description 52
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 46
- 241000208125 Nicotiana Species 0.000 title claims abstract description 39
- 201000010099 disease Diseases 0.000 title claims abstract description 39
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title claims abstract description 39
- 230000002265 prevention Effects 0.000 title claims abstract description 8
- 230000009261 transgenic effect Effects 0.000 claims abstract description 37
- 208000035240 Disease Resistance Diseases 0.000 claims abstract description 14
- 108091026890 Coding region Proteins 0.000 claims abstract description 9
- 230000002708 enhancing effect Effects 0.000 claims abstract description 5
- 241000589771 Ralstonia solanacearum Species 0.000 claims abstract description 4
- 238000000034 method Methods 0.000 claims description 15
- 244000061176 Nicotiana tabacum Species 0.000 claims description 14
- 230000014509 gene expression Effects 0.000 claims description 13
- 239000013604 expression vector Substances 0.000 claims description 10
- 241000589158 Agrobacterium Species 0.000 claims description 7
- 238000012216 screening Methods 0.000 claims description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 230000000813 microbial effect Effects 0.000 claims description 4
- 230000008635 plant growth Effects 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- 230000001737 promoting effect Effects 0.000 claims description 4
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 claims description 3
- 230000001404 mediated effect Effects 0.000 claims description 3
- 238000011426 transformation method Methods 0.000 claims description 3
- 239000003337 fertilizer Substances 0.000 claims description 2
- 241000196324 Embryophyta Species 0.000 abstract description 47
- 238000011161 development Methods 0.000 abstract description 5
- 238000010353 genetic engineering Methods 0.000 abstract description 2
- 238000006243 chemical reaction Methods 0.000 description 12
- 238000011081 inoculation Methods 0.000 description 11
- 108020004414 DNA Proteins 0.000 description 9
- 238000012258 culturing Methods 0.000 description 9
- 239000013598 vector Substances 0.000 description 9
- 239000012634 fragment Substances 0.000 description 6
- 239000001963 growth medium Substances 0.000 description 6
- 238000003753 real-time PCR Methods 0.000 description 6
- 239000002299 complementary DNA Substances 0.000 description 5
- 238000010276 construction Methods 0.000 description 5
- 238000010586 diagram Methods 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 238000009395 breeding Methods 0.000 description 4
- 230000001488 breeding effect Effects 0.000 description 4
- 230000002018 overexpression Effects 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 238000010839 reverse transcription Methods 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 108091092584 GDNA Proteins 0.000 description 3
- 230000003213 activating effect Effects 0.000 description 3
- 238000001976 enzyme digestion Methods 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 3
- 239000010931 gold Substances 0.000 description 3
- 229910052737 gold Inorganic materials 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 230000004544 DNA amplification Effects 0.000 description 2
- 239000012880 LB liquid culture medium Substances 0.000 description 2
- 108091023040 Transcription factor Proteins 0.000 description 2
- 102000040945 Transcription factor Human genes 0.000 description 2
- 238000000246 agarose gel electrophoresis Methods 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 238000010804 cDNA synthesis Methods 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000003973 irrigation Methods 0.000 description 2
- 230000002262 irrigation Effects 0.000 description 2
- 229930027917 kanamycin Natural products 0.000 description 2
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 2
- 229960000318 kanamycin Drugs 0.000 description 2
- 229930182823 kanamycin A Natural products 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 241000219195 Arabidopsis thaliana Species 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 241000758706 Piperaceae Species 0.000 description 1
- 241000208292 Solanaceae Species 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 244000061458 Solanum melongena Species 0.000 description 1
- 235000002597 Solanum melongena Nutrition 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000005562 fading Methods 0.000 description 1
- 208000006278 hypochromic anemia Diseases 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000003375 plant hormone Substances 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 235000012015 potatoes Nutrition 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- JQXXHWHPUNPDRT-WLSIYKJHSA-N rifampicin Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C([O-])=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N1CC[NH+](C)CC1 JQXXHWHPUNPDRT-WLSIYKJHSA-N 0.000 description 1
- 229960001225 rifampicin Drugs 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 238000011222 transcriptome analysis Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000003827 upregulation Effects 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
- C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
- C12N15/8281—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for bacterial resistance
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
- C12N15/8202—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation by biological means, e.g. cell mediated or natural vector
- C12N15/8205—Agrobacterium mediated transformation
Abstract
The invention provides application of a disease-resistant gene NtTBWRG1 in tobacco bacterial wilt prevention and treatment, and belongs to the technical field of genetic engineering. The invention provides application of a disease-resistant gene NtTBWRG1 in prevention and treatment of tobacco bacterial wilt caused by Ralstonia solanacearum, and the coding sequence of the gene is shown as SEQ ID NO: 1. The disease-resistant gene can be effectively used in the cultivation of tobacco bacterial wilt resistant varieties, achieves the aim of obviously enhancing the bacterial wilt resistance of tobacco, achieves the disease resistance level by the bacterial wilt disease index of 20-30 of transgenic plants, and has important application value and good development prospect.
Description
Technical Field
The invention belongs to the technical field of genetic engineering, and particularly relates to application of a disease-resistant gene NtTBWRG1 in tobacco bacterial wilt prevention and treatment.
Background
Bacterial wilt of tobacco is a bacterial disease caused by ralstonia solanacearum, is a typical vascular bundle disease, and can occur in roots, stems and leaves. Tobacco bacterial wilt is widely distributed in China, and in recent years, the hazard range of the tobacco bacterial wilt is gradually expanded and spread from south to north in China, and dead tobacco plants in the whole field are caused when serious, so that great economic loss is caused for tobacco production. At present, no effective control method for tobacco bacterial wilt exists, and the development of disease-resistant genes is a fundamental way for solving the harm of bacterial wilt.
At present, bacterial wilt resistance-related genes have been obtained in a plurality of solanaceae crops such as tomatoes, eggplants, potatoes, peppers and the like, and model plants such as arabidopsis thaliana. However, tobacco is one of the most important commercial crops in China, and the development and research work of the bacterial wilt resistance gene is relatively lagged. In recent years, through transcriptome analysis before and after bacterial wilt of tobacco, genes which are subjected to bacterial wilt infection induction expression are discovered, and after the genes are over-expressed in tobacco, bacterial wilt resistance of transgenic tobacco can be enhanced to a certain extent. For example, overexpression of transcription factors NtWRKY50 and NtPR-Q can induce up-regulation of plant hormone SA and JA synthesis related gene expression, and enhance plant resistance to diseases; overexpression of NtPR1a can activate the expression of related defense genes and enhance the bacterial wilt resistance of transgenic plants; overexpression of NtNF 217 can reduce bacterial wilt propagation in transgenic tobacco, etc. However, most of these genes are transcription factors, and their induced bacterial wilt-resistant effects are limited. Therefore, more disease-resistant genes with stronger functions need to be discovered from tobacco, and new gene resources and strategies are provided for breeding bacterial wilt-resistant tobacco varieties, so that the method has important application prospects.
Disclosure of Invention
The invention provides application of a disease-resistant gene NtTBWRG1 in tobacco bacterial wilt prevention and treatment, the disease-resistant gene can be effectively used in cultivation of tobacco bacterial wilt resistant varieties, the purpose of remarkably enhancing bacterial wilt resistance of tobacco is achieved, bacterial wilt disease index of transgenic plants is 20-30, disease resistance level is achieved, and important application value and good development prospect are achieved.
In order to achieve the aim, the invention provides application of a disease-resistant gene NtTBWRG1 in prevention and treatment of tobacco bacterial wilt caused by Ralstonia solanacearum, and the coding sequence of the gene is shown as SEQ ID NO: 1.
The invention provides an application of an over-expressed NtTBWRG1 gene in obviously enhancing bacterial wilt resistance of tobacco, and the coding sequence of the gene is shown as SEQ ID NO: 1.
The invention provides a construction method of a transgenic tobacco plant with bacterial wilt resistance, which comprises the following steps:
constructing an expression vector 35S of an anti-disease gene NtTBWRG1, wherein the expression vector is NtTBWRG1;
the 35S:NtTBWRG1 expression vector is transferred into a tobacco susceptible variety Cubi No. CB-1 by using an agrobacterium strain LBA4404 mediated leaf disc transformation method, and the transgenic tobacco plant with bacterial wilt resistance is obtained through screening by hygromycin screening markers.
Preferably, the expression level of NtTBWRG1 in the transgenic tobacco plant is improved by 1.25-7.22 times compared with that of a non-transgenic control CB-1.
Preferably, the bacterial wilt disease index of the transgenic tobacco plant is 20-30.
The invention provides application of a disease-resistant gene NtTBWRG1 in preparation of a preparation for promoting tobacco plant growth, wherein the coding sequence of the gene is shown in SEQ ID NO: 1.
Preferably, the tobacco plant growth promoting agent is a microbial agent or microbial fertilizer.
Compared with the prior art, the invention has the advantages and positive effects that:
under the background that high-efficiency specific disease resistance genes are absent in the current tobacco bacterial wilt breeding, the invention provides effective disease resistance genes for the functional research and biological breeding of the tobacco bacterial wilt resistance genes, and can be used for cultivating tobacco bacterial wilt resistance varieties, thereby realizing the purpose of remarkably enhancing the bacterial wilt resistance of tobacco, and the bacterial wilt disease index of transgenic plants is 20-30, thereby reaching the disease resistance level. Therefore, the disease-resistant gene has important application value and good development prospect in tobacco biological breeding.
Drawings
FIG. 1 is a schematic diagram of the bands of the PCR products obtained according to the examples of the present invention;
FIG. 2 is a schematic diagram of the construction process of the vector pCAMBIA1300 according to the embodiment of the present invention;
FIG. 3 is a diagram showing the acquisition of transgenic plants provided by an embodiment of the present invention;
FIG. 4 shows the detection of the expression level of the NtTBWRG1 gene in transgenic plants according to the examples of the present invention;
FIG. 5 is a schematic view of disease resistance at seedling stage according to an embodiment of the present invention;
FIG. 6 is a schematic view of a seedling stage disease index according to an embodiment of the present invention;
FIG. 7 is a schematic diagram of adult plant disease resistance provided by an embodiment of the present invention;
FIG. 8 is a schematic diagram of the disease index of the adult plant according to the embodiment of the present invention.
Detailed Description
The following description of the technical solutions in the embodiments of the present invention will be clear and complete, and it is obvious that the described embodiments are only some embodiments of the present invention, but not all embodiments. All other embodiments, which can be made by those skilled in the art based on the embodiments of the invention without making any inventive effort, are intended to be within the scope of the invention.
Example 1 obtaining of PCR product of disease resistance Gene NtTBWRG1
Extracting RNA of root system of tobacco variety Cuibi No. (CB-1) by using reverse transcription kitOne-Step gDNARemoval and cDNASynthesis SuperMix reverse transcribes RNA into cDNA. Wherein: the reverse transcription reaction system is as follows: 1. Mu.g of total RNA, 1. Mu.L of an anchor Oligo (dT) 18primer, 10. Mu.L of a 2 XS reaction mix,RT/RI Enzyme mix 1μL,gDNA remover 1μL,RNase-free H 2 o makes up a total volume of 20. Mu.L. The reaction procedure is: 30min at 42 ℃; and 5s at 85 ℃.
The cDNA was used as a template, and the gene coding sequence was amplified using a gene amplification primer using high fidelity enzyme TransStart FastPfu Fly DNA. Wherein: the PCR reaction system is as follows: cDNA 2. Mu.L, forward primer 1. Mu.L, reverse primer 1. Mu.L, 5 XFly buffer 10. Mu.L, dNTP mix 10. Mu.L, pfu Fly 2. Mu.L, ddH 2 O24. Mu.L, total volume 50. Mu.L. The gene amplification primers are as follows:
NtTBWRG1-F:GGTACCaATGGCTGAAGCAGCAGTTTCC
NtTBWRG1-R:GGTACCTCAATCAGTATTGACATTCGT
the amplification procedure was: 3min at 95 ℃;95℃15s,55℃15s,72℃3min,35 PCR cycles, 72℃10min.
Agarose gel electrophoresis is carried out on the amplified product, and after the electrophoresis is finished, the DNA fragment recovery kit produced by the full gold company is utilizedPCR Purification Kit) recovering the target band, wherein the size of the target band is 2856bp, and the coding sequence of the gene is shown as SEQ ID NO: 1. Specific steps for gel recovery are described in the specification.
Example 2 vector pCAMBIA1300 construction
The recovered target band is connected to a binary vector pCAMBIA1300 vector by an enzyme cutting connection method. The product and the vector were first purified and subjected to cleavage treatment using KpnI restriction enzyme. The enzyme digestion reaction system is as follows: DNA 20. Mu.L, 5 Xbuffer 10. Mu.L, kpnI 5. Mu.L, ddH 2 O15. Mu.L, total volume 50. Mu.L. The enzyme digestion reaction conditions are as follows: 30min at 37℃and 5s at 85 ℃. After enzyme digestion, the DNA fragment recovery kit produced by the whole golden company is utilizedPCR Purification Kit) recovering the DNA fragments and linearized vector fragments, the gel recovery being described in detail in the description thereof.
The obtained digested gene DNA fragment was ligated with a linearized vector fragment (using T4 DNA ligase from Thermo Fisher Scientific, see the instructions of the company for ligation systems). The ligation reaction was gently mixed and reacted overnight at 16℃and then transformed by adding 5. Mu.L of the constructed vector to 50. Mu.L of competent cells by heat shock transformation. The conversion conditions are as follows: placing on ice for 30min, heat-shocking at 42 deg.C for 30s, placing on ice for 5min, adding 500 μL of liquid LB culture medium, activating thallus at 37 deg.C for 1 hr, and finally uniformly coating on solid LB culture medium containing 50mg/L kanamycin, and culturing at 37 deg.C for 8-10 hr. After single colony is grown, positive clone is identified by adopting a PCR and sequencing method, and the fact that the escherichia coli contains a 35S:NtTBWRG1 expression vector with correct construction is confirmed, wherein the construction process is shown in figure 2.
EXAMPLE 3 transgenic plant acquisition
Agrobacterium LBA4404 has the ability to infect plants and transfer genes, so a constructed 35S: ntTBWRG1 expression vector needs to be transferred into Agrobacterium. The correctly sequenced vector was transformed into Agrobacterium competent LBA4404 by freeze thawing. mu.L of the carrier was added to 50. Mu.L of competent cells, and the mixture was left on ice for 5min. Treating in liquid nitrogen for 5min, adding 500 μl of liquid LB culture medium after ice-laying for 5min, culturing at 28deg.C for 2 hr, uniformly coating on solid LB culture medium containing 50mg/L kanamycin and rifampicin, and standing at 28deg.C for 2-3d. After single colony was grown, positive clones were identified by PCR and sequencing to confirm that 35s:nttbwrg1 expression vector was transferred into agrobacterium LBA4404.
The 35S:NtTBWRG1 expression vector is transferred into a tobacco susceptible variety Cubi No. (CB-1) by using an agrobacterium strain LBA4404 mediated leaf disc transformation method, and a transgenic positive plant is obtained through screening by a hygromycin screening marker. Further extracting DNA of the transgenic plant as a template, performing PCR amplification by using a 35S specific promoter primer, and finally identifying 14 positive plants. Wherein: the PCR reaction system is as follows: 1. Mu.L of DNA, 1. Mu.L of forward primer, 1. Mu.L of reverse primer, 10. Mu.L of 5 Xbuffer, 10. Mu.L of dNTP mix, and goldDNAPolymerase 2μL,ddH 2 O25. Mu.L, total volume 50. Mu.L. The 35S specific promoter primer sequence is as follows:
35S-F:GAATTTCGACCTGCAGGT;
35S-R:GATAGTGGGATTGTGCGT。
the amplification procedure was: 3min at 95 ℃;95℃15s,55℃15s,72℃30s,35 PCR cycles, 72℃10min. Agarose gel electrophoresis is carried out on the amplified product, after the gel is dyed by EB, ultraviolet light is used for detecting electrophoresis bands, as shown in figure 3, DNA bands with 582bp size are amplified in transgenic positive plants, and non-transgenic empty control (CB-1) has no amplified bands.
Example 4 detection of expression level of NtTBWRG1 Gene in transgenic plants
Extracting total RNA of transgenic plant root system by using reverse transcription kitOne-Step gDNA Removal and cDNA Synthesis SuperMix reverse transcribes RNA into cDNA. Wherein: the reverse transcription reaction system is as follows: total RNA 1. Mu.g, anchor Oligo (dT) 18primer 1. Mu.L, 2 XS reaction mix 10. Mu.L, & lt/EN & gt>RT/RI Enzyme mix 1μL,gDNA remover 1μL,RNase-free H 2 O makes up a total volume of 20. Mu.L. The reaction procedure is: 42 ℃ for 15min; and 5s at 85 ℃.
The cDNA was used as a template, and the expression level of the NtTBWRG1 gene was detected by a real-time fluorescent quantitative PCR (qPCR) technique, and 3 biological repeats were set. By using whole goldGreen qPCR SuperMix qPCR reactions were performed. The system is as follows: 1. Mu.L of DNA, 0.4. Mu.L of forward primer, 0.4. Mu.L of reverse primer, & lt/EN & gt>Green qPCR SuperMix 10μL,ddH 2 O8.2. Mu.L, total volume 20. Mu.L. The ABI7500 PCR instrument is adopted for PCR reaction, and the conditions are as follows: 94 ℃ for 30s;94℃for 5s,60℃for 34s,40 PCR cycles. The expression level of NtTBWRG1 in the non-transgenic control variety CB-1 was set to 1.
As shown in the qPCR results of FIG. 4, the expression level of NtTBWRG1 in transgenic plants #1- #14 was increased by 1.25-7.22 times compared with that of the non-transgenic control.
EXAMPLE 5 seedling disease resistance
And taking a susceptible variety CB-1 as a control, selecting #3 and #9 transgenic plants with relatively high expression level of NtTBWRG1 for seedling stage inoculation identification of bacterial wilt disease resistance, and setting 3 biological repetitions for experiments, wherein 25 plants are repeated. Culturing tobacco seedlings to a four-leaf one-heart period in a climatic chamber at 25 ℃, and inoculating bacterial wilt by a root irrigation inoculation method.
The inoculation conditions are as follows: activating strain GMI1000 (NCBI accession number AF 295251) on TTC solid culture medium by streaking, culturing in 30 deg.C incubator for 2-3 days, picking colony, culturing in LB liquid culture medium, culturing at 30deg.C and 200rpm to OD 600 =1.0, dilute the bacterial solution to OD 600 =1.0 ready for use. 10mL of diluted bacterial liquid is inoculated at four weeks of the root of each strain, and the strain is cultured for 2 weeks after inoculation. The culture conditions were 35℃and 80% relative humidity.
As shown in FIG. 5, the results demonstrate that most plants of the non-transgenic control variety CB-1 have been fatigued 14 days after inoculation, while most plants of transgenic plants #3 and #9 still grew normally, exhibiting higher resistance to bacterial wilt.
EXAMPLE 6 Miao national disease index
The disease conditions of the plants 14 days after inoculation were counted, and the results are shown in Table 1. The statistical criteria are:
level 0: tobacco seedlings have no disease symptoms;
stage 1: 1-2 leaves wilt, or the stem base green strip spot is less than 1/3 of the plant height;
3 stages: 2-3 leaves wilt or stem base green strip spot is 1/3-1/2 of plant height;
5 stages: 1-2 healthy leaves, or 1/2-2/3 of the plant height of the stem basal part green strip removing spots;
7 stages: leaf wilting or stem basal green strip spot removing accounts for more than 2/3 of plant height;
stage 9: the whole plant dies.
TABLE 1 seed stage plant disease conditions
Disease level | 0 | 1 | 3 | 5 | 7 | 9 |
CB-1 | 0 | 0 | 5 | 11 | 24 | 35 |
#3 | 16 | 22 | 19 | 18 | 0 | 0 |
#9 | 35 | 25 | 12 | 3 | 0 | 0 |
The disease index calculation formula is as follows:
as a result, as shown in FIG. 6, for the disease index at seedling stage, the control strain CB-1 was 83, and the transgenic plant #3 was 25 and #9 was 11. This also indicates that the higher the expression level of the NtTBWRG1 gene, the more resistant the transgenic plants to bacterial wilt.
Example 7 adult plant disease resistance
And selecting #3 and #9 transgenic plants with relatively high expression quantity of NtTBWRG1 by taking the infected variety CB-1 as a control to carry out bacterial wilt disease resistance identification in the adult stage. The experiment was set up with 3 biological replicates of 25 strains each. In the test field, tobacco seedlings naturally grow to 7 months of high temperature and high humidity, and bacterial wilt is inoculated by a root irrigation inoculation method on 7 months and 1 day.
The inoculation conditions are as follows: activating strain GMI1000 (NCBI accession number AF 295251) on TTC solid culture medium by streaking, culturing in 30 deg.C incubator for 2-3 days, picking colony, culturing in LB liquid culture medium, and culturing at 30 deg.C and 200rpm to OD 600 =1.0, dilute the bacterial solution to OD 600 =1.0 ready for use. 100mL of diluted bacterial liquid is inoculated at four weeks of the root of each plant tobacco, and the disease condition of the plant is observed and counted 60 days after inoculation.
As can be seen from the results shown in FIG. 7, the non-transgenic control strain CB-1 has been desiccated and dead for a majority of plants 60 days after field inoculation, while the transgenic plants #3 and #9 have grown normally for a majority of plants, with leaves kept green, showing better resistance to bacterial wilt.
Example 8 adult plant disease index
The disease conditions of the plants 60 days after inoculation were counted, and the results are shown in Table 2. The statistical criteria are:
level 0: the whole plant has no disease symptoms;
stage 1: the basal part of the stem is occasionally chlorosis;
3 stages: the basal part of the stem has fading spots or a few leaves wilting at the side with strip spots;
5 stages: the stem part has black streak, but does not reach the top end of the plant, or leaves wilting more than half of the disease measurement;
7 stages: the black streak of the stem reaches the top end of the plant, or more than 2/3 of the leaves wilt;
stage 9: the whole plant is basically dead.
TABLE 2 plant disease conditions at the adult stage
The disease index calculation formula is as follows:
as can be seen from the results shown in FIG. 8, the control strain was 90, and the transgenic plants #3 and #9 were 32 and 19, respectively, for the adult stage disease index. This also shows that the overexpression of the NtTBWRG1 gene significantly enhances bacterial wilt resistance of tobacco.
Claims (7)
1. The application of the disease resistance gene NtTBWRG1 in the prevention and treatment of tobacco bacterial wilt caused by Ralstonia solanacearum is characterized in that the coding sequence of the gene is shown as SEQ ID NO: 1.
2. The application of the over-expressed NtTBWRG1 gene in obviously enhancing the bacterial wilt resistance of tobacco is characterized in that the coding sequence of the gene is shown in SEQ ID NO: 1.
3. A method of constructing a transgenic tobacco plant having bacterial wilt resistance comprising the steps of:
constructing an expression vector 35S of an anti-disease gene NtTBWRG1, wherein the expression vector is NtTBWRG1;
the 35S:NtTBWRG1 expression vector is transferred into a tobacco susceptible variety Cubi No. CB-1 by using an agrobacterium strain LBA4404 mediated leaf disc transformation method, and the transgenic tobacco plant with bacterial wilt resistance is obtained through screening by hygromycin screening markers.
4. The method according to claim 3, wherein the expression level of NtTBWRG1 in the transgenic tobacco plant is increased by 1.25-7.22 times as compared to the non-transgenic control CB-1.
5. The method according to claim 3, wherein the bacterial wilt disease index of the transgenic tobacco plant is 20-30.
6. The application of the disease resistance gene NtTBWRG1 in the preparation of a preparation for promoting tobacco plant growth is characterized in that the coding sequence of the gene is shown in SEQ ID NO: 1.
7. The use according to claim 6, wherein the agent for promoting tobacco plant growth is a microbial agent or microbial fertilizer.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311200356.5A CN117265002A (en) | 2023-09-18 | 2023-09-18 | Application of disease-resistant gene NtTBWRG1 in prevention and treatment of tobacco bacterial wilt |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311200356.5A CN117265002A (en) | 2023-09-18 | 2023-09-18 | Application of disease-resistant gene NtTBWRG1 in prevention and treatment of tobacco bacterial wilt |
Publications (1)
Publication Number | Publication Date |
---|---|
CN117265002A true CN117265002A (en) | 2023-12-22 |
Family
ID=89217080
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202311200356.5A Pending CN117265002A (en) | 2023-09-18 | 2023-09-18 | Application of disease-resistant gene NtTBWRG1 in prevention and treatment of tobacco bacterial wilt |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN117265002A (en) |
-
2023
- 2023-09-18 CN CN202311200356.5A patent/CN117265002A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2022135246A1 (en) | R gene for controlling matching of soybean-rhizobium, protein and use thereof | |
CN110819639B (en) | Tobacco low-temperature early-flowering related gene NtDUF599 and application thereof | |
CN110358772B (en) | OsEBP89 gene for improving abiotic stress resistance of rice, and preparation method and application thereof | |
CN110004154B (en) | Application of tea tree CsJAZ1 gene | |
CN102002101A (en) | Plant root development related protein ZmNR1 and coding gene thereof | |
CN109180791B (en) | Gene related to plant drought tolerance, and coding protein and application thereof | |
CN113403325B (en) | Tea tree orphan gene CsOG3 and application thereof in improving cold resistance of tea trees | |
CN109943579B (en) | Lilium regale LrCCoAOMT gene and application thereof | |
CN108034662B (en) | Application of wheat stripe rust PSTG _06025 gene in stripe rust prevention and treatment and cultivation method of stripe rust resistant wheat | |
CN115992153A (en) | Wheat stem rot resistance gene TaP CS, encoding protein and application thereof | |
CN115976052A (en) | Wheat stem basal rot resistance gene TaHSP18.6, expression product, recombinant vector and application thereof | |
CN115896045A (en) | Application of birch pear E3 ubiquitin ligase gene PbrATL18 in genetic improvement of plant drought resistance and anthracnose | |
CN117265002A (en) | Application of disease-resistant gene NtTBWRG1 in prevention and treatment of tobacco bacterial wilt | |
CN112322635A (en) | Coding sequence of larch growth and development regulating gene and its application | |
CN110964729A (en) | Cloning method, application and application method of common wheat gene TaSNX1 | |
CN114591984B (en) | Application of OsAP79 gene in inducing rice to resist brown planthoppers | |
CN115960952B (en) | Expression vector for over-expressing corn ZmHB53 gene, construction method and application thereof in improving drought tolerance of plants | |
CN115873085B (en) | Application of soybean gene GmMAX2a in plant stress resistance | |
CN110129338B (en) | Corn transcription factor ZmEREB160 gene and application thereof | |
CN117603999B (en) | Soybean GmSKT gene and application thereof in soybean anti-leaf roller | |
CN117126879B (en) | Application of tomato SlSUVH1 gene in regulation and control of plant virus resistance and transgenic plant cultivation method | |
CN110295192B (en) | Bivalent RNAi expression vector for constructing TYLCV and ToCV by Gateway technology and application thereof | |
CN116200401B (en) | Application of feather needle grass sugar transporter gene SpSWEET13 in promotion of plant root sticky soil | |
CN117363629B (en) | Citrus CsGATA gene and method for enhancing citrus canker resistance by using same | |
WO2022213453A1 (en) | Use of aluminum ion receptor alr1 gene or protein for regulating aluminum resistance of plant |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |